Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration

To prevent deterioration of VA, patients with nAMD seem to be willing to accept a high treatment burden with regular intravitreal injections at short intervals and long periods of waiting, treatment, and traveling for their consultations.